Prudentia Sciences
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $20M
Investors
- 5
About Prudentia Sciences
Founded in 2023 and based in Massachusetts, US, Prudentia Sciences, Inc. specializes in AI-driven decision support for the biopharma industry. The company was founded by its CEO, Sadiqa Mahmood. In January 2026, Prudentia Sciences, Inc. Prudentia Sciences offers an artificial intelligence-powered asset diligence and valuation platform designed to enhance decision-making in the biopharma sector through AI-powered asset diligence and valuation. The company leverages AI and human expertise to analyze drug assets.
Who invested in Prudentia Sciences
5 investors across 1 round
See all investors in Prudentia Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 7, 2026
Amount
$20M
Investors
Questions about Prudentia Sciences
Who invested in Prudentia Sciences?
Prudentia Sciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prudentia Sciences raised?
Prudentia Sciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prudentia Sciences last raise money?
Prudentia Sciences's most recent round on record is a Series A, in Jan 2026.
What does Prudentia Sciences do?
Founded in 2023 and based in Massachusetts, US, Prudentia Sciences, Inc.
Where is Prudentia Sciences headquartered?
Prudentia Sciences is headquartered in Cambridge, US.
Which VCs invest in companies like Prudentia Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Prudentia Sciences's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Prudentia Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.